DNTH Dianthus Therapeutics
- 23.050
- -1.520-6.19%
Dianthus Therapeutics News
Dianthus Therapeutics | 10-Q: Quarterly report
Dianthus Therapeutics | 424B3: Prospectus
Dianthus Therapeutics | 8-K: Current report
Dianthus Therapeutics | ARS: Annual Report to Security Holders
Dianthus Therapeutics | DEFA14A: Others
Dianthus Therapeutics | DEF 14A: Definitive information statements
Dianthus Therapeutics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Fairmount Funds Management LLC(9.99%),Fairmount Healthcare Fund II LP(9.99%), etc.
Dianthus Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Fairmount Funds Management LLC
Dianthus Therapeutics | EFFECT: Others
Dianthus Therapeutics | CORRESP: CORRESP
Dianthus Therapeutics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Dianthus Therapeutics | S-1/A: General form for registration of securities under the Securities Act of 1933 (Amendment)
Dianthus Therapeutics | 10-K: Annual report
Dianthus Therapeutics | 8-K: Current report
Dianthus Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Andrew J. Schwab(5.7%),Kush Parmar(5.7%), etc.
Dianthus Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Third Rock Ventures IV, L.P.(0%),Third Rock Ventures GP IV, L.P.(0%), etc.
Dianthus Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Citadel Advisors LLC(0.0%),Citadel Advisors Holdings LP(0.0%), etc.
Dianthus Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-GV 2016, L.P.(1.4%),GV 2016 GP, L.P.(1.4%), etc.
Dianthus Therapeutics | S-1/A: General form for registration of securities under the Securities Act of 1933 (Amendment)
Dianthus Therapeutics | CORRESP: CORRESP
Analysis
Price Target
No Data
